Provia Labs Acquires the Vault Stem Cell Bank’s Dental Stem Cell Client Base and Distribution Agreements

we chose Provia precisely because of their investment into quality…and specifically the investment they’ve made into their cGMP facility.

Provia Laboratories LLC (“Provia”) completed a transaction with the Vault Biobank (“Vault”) to take over the Vault’s dental stem cell business’ client agreements and distribution agreements. As part of the terms of the transaction, Provia will provide continuous storage services for existing clients, and provide its Store-A-Tooth services to new clients engaged through the Vault’s former dental office distributors.

Adam Houtman, Chief Executive Officer of the Vault explains, “When selecting a firm to entrust our client’s valuable samples, we chose Provia precisely because of their investment into quality, the strength of their team, and specifically the investment they’ve made into their cGMP facility. We feel confident that our client’s samples will be in the best possible hands.”

Provia’s state-of-the-art stem cell laboratory operates under the FDA’s current good manufacturing practice (“cGMP”) guidelines for processing human cell and tissue products.    Provia offers stem cell biobanking services for consumers, biostorage services for commercial customers, as well as a suite of cGMP processing and related services for clinical activities. Provia’s focus is on small batch cell processing, manufacturing, and biobanking services such as those for autologous use (cells from you, for you) whereby a single patient’s sample is manufactured for a single use.

Under the brand Store-A-Tooth™, Provia offers the only cGMP dental stem cell banking solution for consumers.

Processing client samples within a cGMP operation is critical to the future clinical use of those…

Full article from the Source…

Back to Top